Changes in symptoms of anhedonia with psilocybin-assisted psychotherapy: A secondary analysis of a randomized clinical trial for treatment-resistant depression

被引：0
|
作者：
Kaczmarek, Erica [1 ]
Rosenblat, Joshua [2 ]
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
来源：
BIPOLAR DISORDERS | 2024年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P77
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [21] Effect of Adjunctive Simvastatin on Depressive Symptoms Among Adults With Treatment-Resistant Depression A Randomized Clinical Trial
    Husain, M. Ishrat
    Chaudhry, Imran B.
    Khoso, Ameer B.
    Kiran, Tayyeba
    Khan, Nawaz
    Ahmad, Farooq
    Hodsoll, John
    Husain, M. Omair
    Naqvi, Haider A.
    Nizami, Asad T.
    Chaudhry, Nasim
    Khan, Hazrat A.
    Minhas, Fareed
    Meyer, Jeffrey H.
    Ansari, Moin A.
    Mulsant, Benoit H.
    Husain, Nusrat
    Young, Allan H.
    JAMA NETWORK OPEN, 2023, 6 (02) : e230147
  • [22] Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder A Randomized Clinical Trial
    Bogenschutz, Michael P.
    Ross, Stephen
    Bhatt, Snehal
    Baron, Tara
    Forcehimes, Alyssa A.
    Laska, Eugene
    Mennenga, Sarah E.
    O'Donnell, Kelley
    Owens, Lindsey T.
    Podrebarac, Samantha
    Rotrosen, John
    Tonigan, J. Scott
    Worth, Lindsay
    JAMA PSYCHIATRY, 2022, 79 (10) : 953 - 962
  • [23] Psilocybin reduces symptoms in treatment resistant depression, trial results show
    Iacobucci, Gareth
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 379 : o2623
  • [24] Results: Of a Multi-Modal Neuroimaging Study of LSD and a Psilocybin for Treatment-Resistant Depression Clinical Trial
    Carhart-Harris, Robin
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S91 - S92
  • [25] Psilocybin-Assisted Treatment of Depression, Anxiety and Substance use Disorders: Neurobiological Basis and Clinical Application
    Lasch, Anna
    Schweikert, Timo
    Dora, Eva
    Kolb, Theresa
    Schurig, Hanne Lilian
    Walther, Andreas
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2024, 92 (06) : 230 - 245
  • [26] Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial
    Rieser, Nathalie M.
    Bitar, Raoul
    Halm, Simon
    Rossgoderer, Christina
    Gubser, Ladina P.
    Thevenaz, Maeva
    Kreis, Yara
    von Rotz, Robin
    Nordt, Carlos
    Visentini, Monika
    Moujaes, Flora
    Engeli, Etna J. E.
    Ort, Andres
    Seifritz, Erich
    Vollenweider, Franz X.
    Herdener, Marcus
    Preller, Katrin H.
    ECLINICALMEDICINE, 2025, 82
  • [27] Modulation of the inflammatory response benefits treatment-resistant bipolar depression: A randomized clinical trial
    Halaris, Angelos
    Cantos, Adriana
    Johnson, Katherine
    Hakimi, Michael
    Sinacore, James
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 261 : 145 - 152
  • [28] Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression A Randomized Clinical Trial
    Ramos, Matheus Rassi F.
    Goerigk, Stephan
    Aparecida da Silva, Valquiria
    Cavendish, Beatriz Araujo
    Pinto, Bianca Silva
    Papa, Cassio Henrique Gomide
    Resende, Joao Vitor
    Klein, Izio
    Carneiro, Adriana Munhoz
    de Sousa, Juliana Pereira
    Vidal, Kallene Summer Moreira
    Valiengo, Leandro da Costa Lane
    Razza, Lais B.
    Aparicio, Luana Marotti
    Martins, Lisiane
    Borrione, Lucas
    Batista, Mariana
    Moran, Natasha Kouvalesk
    dos Santos, Leonardo Afonso
    Benatti, Rafael
    Pelosof, Rebeca
    Padberg, Frank
    Brunoni, Andre R.
    JAMA PSYCHIATRY, 2025,
  • [29] A Randomized Controlled Trial of Ketamine for Adolescent Treatment-Resistant Depression
    Dwyer, Jennifer
    Yip, Sarah
    Sanacora, Gerard
    Bloch, Michael
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S95 - S95
  • [30] Ketamine in Adolescent Treatment-Resistant Depression: Secondary Outcomes of a Randomized, Midazolam-Controlled Trial
    Dwyer, Jennifer
    Sanacora, Gerard
    Bloch, Michael
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 109 - 109
12345